Light Activated Biomaterials (LAB) Group, Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago Christchurch, Christchurch, 8011, New Zealand.
Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago Christchurch, Christchurch, 8011, New Zealand.
Adv Healthc Mater. 2022 Jan;11(2):e2101873. doi: 10.1002/adhm.202101873. Epub 2021 Nov 8.
The principle challenge for engineering viable, cell-laden hydrogel constructs of clinically-relevant size, is rapid vascularization, in order to moderate the finite capacity of passive nutrient diffusion. A multiscale vascular approach, with large open channels and bulk microcapillaries may be an admissible approach to accelerate this process, promoting overall pre-vascularization for long-term viability of constructs. However, the limited availability of bioinks that possess suitable characteristics that support both fabrication of complex architectures and formation of microcapillaries, remains a barrier to advancement in this space. In this study, gelatin-norbornene (Gel-NOR) is investigated as a vascular bioink with tailorable physico-mechanical properties, which promoted the self-assembly of human stromal and endothelial cells into microcapillaries, as well as being compatible with extrusion and lithography-based biofabrication modalities. Gel-NOR constructs containing self-assembled microcapillaries are successfully biofabricated with varying physical architecture (fiber diameter, spacing, and orientation). Both channel sizes and cell types affect the overall structural changes of the printed constructs, where cross-signaling between both human stromal and endothelial cells may be responsible for the reduction in open channel lumen observed over time. Overall, this work highlights an exciting three-way interplay between bioink formulation, construct design, and cell-mediated response that can be exploited towards engineering vascular tissues.
制造具有临床相关尺寸的、可行的、富含细胞的水凝胶结构的主要挑战是快速血管化,以调节有限的被动营养扩散能力。多尺度血管方法,具有大的开放通道和大量微毛细管,可能是加速这一过程的一种可接受的方法,促进整体预血管化,以提高构建体的长期存活率。然而,具有合适特性的生物墨水的有限可用性,这些特性既支持复杂结构的制造又支持微毛细管的形成,仍然是该领域进展的一个障碍。在这项研究中,研究了硝酮封端明胶(Gel-NOR)作为一种血管生物墨水,具有可调节的物理力学性能,可促进人基质细胞和内皮细胞自组装成微毛细管,并且与挤出和基于光刻的生物制造方式兼容。含有自组装微毛细管的 Gel-NOR 构建体成功地采用不同的物理结构(纤维直径、间距和方向)进行生物制造。通道尺寸和细胞类型都影响打印构建体的整体结构变化,其中人基质细胞和内皮细胞之间的交叉信号可能是导致观察到的开放通道腔随时间缩小的原因。总的来说,这项工作突出了生物墨水配方、构建体设计和细胞介导的反应之间令人兴奋的三向相互作用,可以利用这些相互作用来工程化血管组织。